NEW YORK, Jan. 09, 2019 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:
Levi & Korsinsky, LLP announces that investigations have commenced on behalf of shareholders of the following publicly-traded companies.
Birner Dental Management Services, Inc. BDMS
Merger Announcement: October 3, 2018
Transaction Details: Birner Dental will be purchased by Mid-Atlantic Dental Partners for $10.62 in cash per share. Birner Dental shareholders are also entitled to a Contingent Value Right (CVR) per share, for an additional payment of up to $0.13 per share.
To learn more about the BDMS investigation and your rights, go to: https://www.zlk.com/mna/birner-dental-management-services-inc.
Loxo Oncology, Inc. LOXO
Merger Announcement: January 7, 2019
Transaction Details: Loxo Oncology will be purchased by Eli Lilly and Company LLY for $235 per share.
To learn more about the LOXO investigation and your rights, go to: https://www.zlk.com/mna/loxo-oncology-inc.
MINDBODY, Inc. MB
Merger Announcement: December 24, 2018
Transaction Details: MINDBODY will be purchased by Vista Equity Partners for $36.50 per share.
To learn more about the MB investigation and your rights, go to: https://www.zlk.com/mna/mindbody-inc.
Levi & Korsinsky is a national firm with offices in New York, Connecticut, California, and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
jlevi@levikorsinsky.com
55 Broadway, 10th Floor
New York, NY 10006
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.